Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1

References

• Umanath K , Lewis JB . Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis . 2018;71(6):884–895. doi:10.1053/j.ajkd.2017.10.026 29398179
   PubMed Web of Science ®Google Scholar
• Flyvbjerg A . The role of the complement system in diabetic nephropathy. Nat Rev Nephrol . 2017;13(5):311–318. doi:10.1038/nrneph.2017.31 28262777
   PubMed Web of Science ®Google Scholar
• Geng XD , Wang WW , Feng Z , et al. Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis. J Diabetes Investig . 2019;10(4):972–984. doi:10.1111/jdi.12986
   Web of Science ®Google Scholar
• Jafari D , Malih S , Eslami SS , et al. The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: opening the way for exosomes based therapeutics. Biochimie . 2019;165:76–89. doi:10.1016/j.biochi.2019.07.009 31302163
   PubMed Web of Science ®Google Scholar
• Cosenza S , Ruiz M , Maumus M , Jorgensen C , Noel D . Pathogenic or therapeutic extracellular vesicles in rheumatic diseases: role of mesenchymal stem cell-derived vesicles. Int J Mol Sci . 2017;18(4):889. doi:10.3390/ijms18040889
   PubMed Web of Science ®Google Scholar
• Yamashita T , Takahashi Y , Takakura Y . Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol Pharm Bull . 2018;41(6):835–842. doi:10.1248/bpb.b18-00133 29863072
   PubMed Web of Science ®Google Scholar
• Tung CW , Hsu YC , Shih YH , Chang PJ , Lin CL . Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton) . 2018;23 Suppl 4:32–37. doi:10.1111/nep.13451 30298646
   PubMed Web of Science ®Google Scholar
• Liang X , Zhang L , Wang S , Han Q , Zhao RC . Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci . 2016;129(11):2182–2189. doi:10.1242/jcs.170373 27252357
   PubMed Web of Science ®Google Scholar
• Condrat CE , Thompson DC , Barbu MG , et al. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells . 2020;9(2):276. doi:10.3390/cells9020276
   PubMed Web of Science ®Google Scholar
• Inoue K , Gan G , Ciarleglio M , et al. Podocyte histone deacetylase activity regulates murine and human glomerular diseases. J Clin Invest . 2019;129(3):1295–1313. doi:10.1172/JCI124030 30776024
   PubMed Web of Science ®Google Scholar
• Chen S , Tang Y , Liu Y , et al. Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration. Cell Prolif . 2019;52(5):e12669. doi:10.1111/cpr.12669 31380594
   PubMed Web of Science ®Google Scholar
• Zhang J , Zhang X . Ischaemic preconditioning-induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway. Cell Biochem Funct . 2020.
   Web of Science ®Google Scholar
• Tong Y , Liu S , Gong R , Zhong L , Duan X , Zhu Y . Ethyl vanillin protects against kidney injury in diabetic nephropathy by inhibiting oxidative stress and apoptosis. Oxid Med Cell Longev . 2019;2019:2129350. doi:10.1155/2019/2129350 31781325
   PubMed Web of Science ®Google Scholar
• Xiang E , Han B , Zhang Q , et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther . 2020;11(1):336. doi:10.1186/s13287-020-01852-y 32746936
   PubMed Web of Science ®Google Scholar
• Li P , Bukhari SNA , Khan T , et al. Apigenin-loaded solid lipid nanoparticle attenuates diabetic nephropathy induced by streptozotocin nicotinamide through Nrf2/HO-1/NF-kB signalling pathway. Int J Nanomedicine . 2020;15:9115–9124. doi:10.2147/IJN.S256494 33244230
   PubMed Web of Science ®Google Scholar
• Wang S , Wen X , Han XR , et al. Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy. Cell Prolif . 2018;51(5):e12462. doi:10.1111/cpr.12462 29701296
   PubMed Web of Science ®Google Scholar
• Horii Y , Muraguchi A , Iwano M , et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol . 1989;143(12):3949–3955.2592764
   PubMed Web of Science ®Google Scholar
• Li C , Lei T . Rs12976445 polymorphism is associated with risk of diabetic nephropathy through modulating expression of microRNA-125 and interleukin-6R. Med Sci Monit . 2015;21:3490–3497. doi:10.12659/MSM.894987 26563755
   PubMed Web of Science ®Google Scholar
• Ma J , Zhao N , Du L , Wang Y . Downregulation of lncRNA NEAT1 inhibits mouse mesangial cell proliferation, fibrosis, and inflammation but promotes apoptosis in diabetic nephropathy. Int J Clin Exp Pathol . 2019;12(4):1174–1183.31933932
   PubMed Web of Science ®Google Scholar
• Das F , Maity S , Ghosh-Choudhury N , Kasinath BS , Ghosh Choudhury G . Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation. J Biol Chem . 2019;294(24):9440–9460. doi:10.1074/jbc.RA118.007023 31028173
   PubMed Web of Science ®Google Scholar
• Rosano L , Cianfrocca R , Tocci P , et al. beta-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling. Oncogene . 2013;32(42):5066–5077. doi:10.1038/onc.2012.527 23208497
   PubMed Web of Science ®Google Scholar
• Lenoir O , Milon M , Virsolvy A , et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J Am Soc Nephrol . 2014;25(5):1050–1062. doi:10.1681/ASN.2013020195 24722437
   PubMed Web of Science ®Google Scholar
• Kim Y , Park CW . New therapeutic agents in diabetic nephropathy. Korean J Intern Med . 2017;32(1):11–25. doi:10.3904/kjim.2016.174 28049280
   PubMed Web of Science ®Google Scholar
• Xue C , Mei CL . Polycystic kidney disease and renal fibrosis. Adv Exp Med Biol . 2019;1165:81–100.31399962
   PubMed Web of Science ®Google Scholar
• Jafarinia M , Alsahebfosoul F , Salehi H , Eskandari N , Ganjalikhani-Hakemi M . Mesenchymal stem cell-derived extracellular vesicles: a novel cell-free therapy. Immunol Invest . 2020:1–23.
   Web of Science ®Google Scholar
• Grange C , Tapparo M , Bruno S , et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med . 2014;33(5):1055–1063. doi:10.3892/ijmm.2014.1663 24573178
   PubMed Web of Science ®Google Scholar
• Nagaishi K , Mizue Y , Chikenji T , et al. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep . 2016;6(1):34842. doi:10.1038/srep34842 27721418
   PubMed Web of Science ®Google Scholar
• Ebrahim N , Ahmed IA , Hussien NI , et al. Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells . 2018;7(12):226. doi:10.3390/cells7120226
   PubMed Web of Science ®Google Scholar
• Mendt M , Rezvani K , Shpall E . Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant . 2019;54(Suppl 2):789–792. doi:10.1038/s41409-019-0616-z 31431712
   PubMed Web of Science ®Google Scholar
• Gurunathan S , Kang MH , Jeyaraj M , Qasim M , Kim JH . Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells . 2019;8(4):307. doi:10.3390/cells8040307
   PubMed Web of Science ®Google Scholar
• Ahlborg G , Lindstrom J . Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans. J Appl Physiol . 2002;93(6):2112–2121. doi:10.1152/japplphysiol.00477.2002 12391119
   PubMed Web of Science ®Google Scholar
• Kasztan M , Pollock DM . Impact of ET-1 and sex in glomerular hyperfiltration in humanized sickle cell mice. Clin Sci (Lond) . 2019;133(13):1475–1486. doi:10.1042/CS20190215 31273050
   PubMed Web of Science ®Google Scholar
• Zanatta CM , Veronese FV , Loreto Mda S , et al. Endothelin-1 and endothelin a receptor immunoreactivity is increased in patients with diabetic nephropathy. Ren Fail . 2012;34(3):308–315. doi:10.3109/0886022X.2011.647301 22250646
   PubMed Web of Science ®Google Scholar
• Fukui M , Nakamura T , Ebihara I , et al. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med . 1993;122(2):149–156.8340699
   PubMed Web of Science ®Google Scholar
• Badr KF , Murray JJ , Breyer MD , Takahashi K , Inagami T , Harris RC . Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest . 1989;83(1):336–342. doi:10.1172/JCI113880 2536045
   PubMed Web of Science ®Google Scholar
• Ergul A . Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res . 2011;63(6):477–482. doi:10.1016/j.phrs.2011.01.012 21292003
   PubMed Web of Science ®Google Scholar